Multiple Myeloma and Principles of Autograft Flashcards

1
Q

What are the risk factors for progression from MGUS?

A

M protein > 15g/L, non IgG MGUS, serum FLC ratio abnormal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is the definition of MGUS?

A

M protein < 30 g/L
clonal plasma cells in BM < 10%
no myeloma defining events

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is the definition of smoldering myeloma?

A

M protein > 30g/L (serum) or > 500mg/24 hours (urine)
clonal plasma cells in BM 10% to 60%
no myeloma defining events

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is the definition of multiple myeloma?

A
clonal BM plasma cells > 10% or > 1 biopsy proven plasmacytoma AND 1 or more MM-defining events:
> 1 CRAB feature
> 1 biomarker of malignancy:
clonal plasma cells in BM > 60%
serum FLC ratio > 100
> 1 MRI focal lesion > 5mm on MRI
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are some of the common clinical presentations for multiple myeloma?

A
bone pain with negative bone scan
low BMD with paraprotein
normo/macrocytic anaemia with high total protein
acute renal failure with anaemia
back pain with anaemia
hyperviscosity
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are the clinical features of hyperviscosity?

A

confusion, headache, visual changes, mucosal haemorrhage, high output heart failure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Which immunoglobulin is most likely to cause hyperviscosity?

A

IgM > IgA > IgG

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What defines stage I multiple myeloma?

A

beta 2 microglobulin < 3.5
albumin > 35
no high risk cytogenetics
normal LDH

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What defines stage II multiple myeloma?

A

beta 2 microgobulin between 3.5 and 5.5

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What defines stage III multiple myeloma?

A

beta 2 microglobulin > 5.5

high risk cytogenetics or elevated LDH

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are the high risk cytogenetic features?

A
17p deletion
translocation (14;16)
translocation (16;20)
translocation (4;14)
1q addition
1p deletion
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What investigations are required for workup of a myeloma patient?

A
FBE and film
UEC
CMP
SPEP, immunofixation
quantification of serum Igs
urinalysis, 24 hr UPEP and immunofixation
BM aspirate and/or biopsy
cytogenetics
serum beta 2 microglobulin
LDH
serum free light chains
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are the findings of FBE, UEC, CMP, protein and albumin in multiple myeloma?

A
normocytic anaemia
cytopaenias
hypercalcaemia
elevated creatinine
elevated protein
low albumin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are the findings on a blood film in multiple myeloma?

A

rouleaux, circulating plasma cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

In what benign conditions may serum free light chain levels be elevated?

A

polyclonal hypergammaglobulinaemia
renal failure
however ratio will be normal -> ratio is only abnormal in monoclonal plasma cell disorder

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is the benefit of measuring the serum free light chain ratio?

A

can detect patients who are only producing a small amount of paraprotein

17
Q

What percentage of patients with AL amyloidosis have an abnormal serum free light chain ratio?

18
Q

In what ways does multiple myeloma cause renal impairment?

A
myeloma cast nephropathy (most common)
light chain deposition disease
amyloidosis
acquired fanconi
hypercalcaemia
hyperuricaemia
19
Q

What is the pathophysiology of myeloma cast nephropathy?

A

paraproteins are filtered through the glomeruls
in the tubule they complex with tamm-horsfall proteins and form casts which block the tubules
endocystosed in the cell and cause a toxic inflammatory cascade (which relies heavily on NFkappaB)

20
Q

What are the morphological features of a bone marrow aspirate in multiple myeloma?

A

dutcher bodies
flame cells
russel bodies
mott cells

21
Q

What proteasome inhibitors are available in Australia for multiple myeloma treatment?

A

bortezomib

carfilzomib

22
Q

What immunomodulators are available in Australia for multiple myeloma treatment?

A

thalidomide
lenalidomide
pomalidomide

23
Q

What monoclonal antibody is available in Australia for multiple myeloma treatment?

A

daratumumab

24
Q

What is the main side effect of bortezomib and thalidomide?

A

neuropathy

25
What is the main side effect of lenalidamide and pomalidomide?
cytopaenia
26
What is the main side effect of carfilzomib?
cardiac problems
27
What is the current induction therapy for both transplant eligibile and ineligible multiple myeloma patients?
bortezomib, lenalidomide and dexamethasone triple therapy
28
What did the results of the MMXI trial show?
that giving patients lenalidomide rather than observing them after transplantation prolongs remission